Literature DB >> 19852889

Nutritional supplements and serum lipids: does anything work?

Mary P McGowan1, Suzanne Proulx.   

Abstract

Hyperlipidemia is a risk factor for the development of coronary heart disease. Many patients decline prescription lipid-lowering agents and opt instead for supplements. Before any supplement can be routinely recommended it is crucial to examine the types of clinical trials that have been performed, the mechanism by which a supplement is felt to alter lipids, the population studied, potential adverse effects, and the possibility that investigators might be biased. Clinical trial evidence strongly supports the notion that both red yeast rice and plant stanols and sterols effectively lower low-density lipoprotein (LDL) cholesterol. Preliminary evidence supports the possibility that green tea catechins and black tea theaflavins may lower LDL. Data do not support an LDL-lowering claim for guggulipid, policosanol, or cinnamon. Finally, there is strong clinical trial evidence suggesting that marine omega-3 fatty acids lower triglycerides.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19852889     DOI: 10.1007/s11883-009-0070-2

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  42 in total

1.  Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases.

Authors:  W S Harris; G Lu; G S Rambjør; A I Wålen; J A Ontko; Q Cheng; S L Windsor
Journal:  Am J Clin Nutr       Date:  1997-08       Impact factor: 7.045

2.  Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2005-11-07       Impact factor: 1.909

Review 3.  n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data.

Authors:  Raffaele De Caterina; Rosalinda Madonna; Alessandra Bertolotto; Erik Berg Schmidt
Journal:  Diabetes Care       Date:  2007-01-24       Impact factor: 19.112

4.  Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia.

Authors:  Hiroyuki Fujita; Tomohide Yamagami
Journal:  Nutr Res       Date:  2008-07       Impact factor: 3.315

5.  An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia.

Authors:  P N Durrington; D Bhatnagar; M I Mackness; J Morgan; K Julier; M A Khan; M France
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

6.  Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.

Authors:  Heiner K Berthold; Susanne Unverdorben; Ralf Degenhardt; Michael Bulitta; Ioanna Gouni-Berthold
Journal:  JAMA       Date:  2006-05-17       Impact factor: 56.272

7.  Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles.

Authors:  Mario A Vermeer; Theo P J Mulder; Henri O F Molhuizen
Journal:  J Agric Food Chem       Date:  2008-12-24       Impact factor: 5.279

8.  Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake.

Authors:  Isabelle Demonty; Rouyanne T Ras; Henk C M van der Knaap; Guus S M J E Duchateau; Linsie Meijer; Peter L Zock; Johanna M Geleijnse; Elke A Trautwein
Journal:  J Nutr       Date:  2008-12-17       Impact factor: 4.798

9.  Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.

Authors:  Dick C Chan; Gerald F Watts; Trevor A Mori; P Hugh R Barrett; Trevor G Redgrave; Lawrence J Beilin
Journal:  Am J Clin Nutr       Date:  2003-02       Impact factor: 7.045

10.  Both free and esterified plant sterols reduce cholesterol absorption and the bioavailability of beta-carotene and alpha-tocopherol in normocholesterolemic humans.

Authors:  Myriam Richelle; Marc Enslen; Corinne Hager; Michel Groux; Isabelle Tavazzi; Jean-Philippe Godin; Alvin Berger; Sylviane Métairon; Sylvie Quaile; Christelle Piguet-Welsch; Laurent Sagalowicz; Hilary Green; Laurent Bernard Fay
Journal:  Am J Clin Nutr       Date:  2004-07       Impact factor: 7.045

View more
  10 in total

Review 1.  The role of red yeast rice for the physician.

Authors:  Ram Y Gordon; David J Becker
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

Review 2.  Flavonoids and age-related disease: risk, benefits and critical windows.

Authors:  J K Prasain; S H Carlson; J M Wyss
Journal:  Maturitas       Date:  2010-02-23       Impact factor: 4.342

3.  Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.

Authors:  Barbara Swanson; Joyce K Keithley; Beverly E Sha; Louis Fogg; Judith Nerad; Richard M Novak; Oluwatoyin Adeyemi; Gregory T Spear
Journal:  Altern Ther Health Med       Date:  2011 Mar-Apr       Impact factor: 1.305

Review 4.  Fish oil supplementation & coronary artery disease: does it help?

Authors:  Subrata Kar; Richard Webel
Journal:  Mo Med       Date:  2012 Mar-Apr

5.  Clinical Practice Guideline for Cardiac Rehabilitation in Korea.

Authors:  Chul Kim; Jidong Sung; Jong Hwa Lee; Won-Seok Kim; Goo Joo Lee; Sungju Jee; Il-Young Jung; Ueon Woo Rah; Byung Ok Kim; Kyoung Hyo Choi; Bum Sun Kwon; Seung Don Yoo; Heui Je Bang; Hyung-Ik Shin; Yong Wook Kim; Heeyoune Jung; Eung Ju Kim; Jung Hwan Lee; In Hyun Jung; Jae-Seung Jung; Jong-Young Lee; Jae-Young Han; Eun Young Han; Yu Hui Won; Woosik Han; Sora Baek; Kyung-Lim Joa; Sook Joung Lee; Ae Ryoung Kim; So Young Lee; Jihee Kim; Hee Eun Choi; Byeong-Ju Lee; Soon Kim
Journal:  Ann Rehabil Med       Date:  2019-06-28

6.  Clinical Practice Guideline for Cardiac Rehabilitation in Korea.

Authors:  Chul Kim; Jidong Sung; Jong Hwa Lee; Won-Seok Kim; Goo Joo Lee; Sungju Jee; Il-Young Jung; Ueon Woo Rah; Byung Ok Kim; Kyoung Hyo Choi; Bum Sun Kwon; Seung Don Yoo; Heui Je Bang; Hyung-Ik Shin; Yong Wook Kim; Heeyoune Jung; Eung Ju Kim; Jung Hwan Lee; In Hyun Jung; Jae-Seung Jung; Jong-Young Lee; Jae-Young Han; Eun Young Han; Yu Hui Won; Woosik Han; Sora Baek; Kyung-Lim Joa; Sook Joung Lee; Ae Ryoung Kim; So Young Lee; Jihee Kim; Hee Eun Choi; Byeong-Ju Lee; Soon Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2019-08-05

Review 7.  Clinical Practice Guideline for Cardiac Rehabilitation in Korea: Recommendations for Cardiac Rehabilitation and Secondary Prevention after Acute Coronary Syndrome.

Authors:  Chul Kim; Jidong Sung; Jong Hwa Lee; Won Seok Kim; Goo Joo Lee; Sungju Jee; Il Young Jung; Ueon Woo Rah; Byung Ok Kim; Kyoung Hyo Choi; Bum Sun Kwon; Seung Don Yoo; Heui Je Bang; Hyung Ik Shin; Yong Wook Kim; Heeyoune Jung; Eung Ju Kim; Jung Hwan Lee; In Hyun Jung; Jae Seung Jung; Jong Young Lee; Jae Young Han; Eun Young Han; Yu Hui Won; Woosik Han; Sora Baek; Kyung Lim Joa; Sook Joung Lee; Ae Ryoung Kim; So Young Lee; Jihee Kim; Hee Eun Choi; Byeong Ju Lee; Soon Kim
Journal:  Korean Circ J       Date:  2019-11       Impact factor: 3.243

8.  Study of the effects of monacolin k and other constituents of red yeast rice on obesity, insulin-resistance, hyperlipidemia, and nonalcoholic steatohepatitis using a mouse model of metabolic syndrome.

Authors:  Makoto Fujimoto; Koichi Tsuneyama; Shao-Yuan Chen; Takeshi Nishida; Jiun-Liang Chen; Yen-Chen Chen; Takako Fujimoto; Johji Imura; Yutaka Shimada
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-20       Impact factor: 2.629

Review 9.  Hydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesity.

Authors:  Md Ashraful Alam; Nusrat Subhan; Hemayet Hossain; Murad Hossain; Hasan Mahmud Reza; Md Mahbubur Rahman; M Obayed Ullah
Journal:  Nutr Metab (Lond)       Date:  2016-04-11       Impact factor: 4.169

10.  Cinnamon as Dietary Supplement Caused Hyperlipidemia in Healthy Rats.

Authors:  Xiaomin Huang; Haiyang Cai; Han Li; Yixun Su; Hui Li; Weihong Li; Chenju Yi; Brian G Oliver; Hui Chen
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-02       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.